Fusion Proteins Market Size, Share, Growth and Forecast 2024-2031

Fusion Proteins Market Size, Share, Industry, Forecast and outlook (2024-2031)

<h2>Global Fusion Proteins Market is Segmented&nbsp;By Product (Immunoglobulin (Ig) fusion protein,&nbsp;Parathyroid hormone (PTH) fusion protein,&nbsp;Recombinant fusion protein,&nbsp;Other&nbsp;), By Application (Biotechnology, Pharmaceutical, Others),&nbsp;and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, &nbsp;2024-2031</h2>&nbsp;<h3>Market Overview</h3><blockquote>The Global "Fusion Proteins Market"&nbsp;is estimated to reach&nbsp;at a CAGR of 10.5% during the forecast period (2024-2031).&nbsp;</blockquote>A fusion protein contains at least two domains encoded by separate genes that have been linked so that these proteins are transcribed and translated as a single unit, yielding a single polypeptide.<h3>Market Dynamics</h3>The global fusion proteins market is expected to grow with increasing applications of fusion proteins.The increasing applications of fusion proteins are expected to drive the market growth in the forecast periodThe increasing application of fusion proteins for pulmonary arterial hypertension is expected to boost market growth. For instance, pulmonary arterial hypertension is a type of pulmonary hypertension caused by the thickening and narrowing of the tiny arteries in your lung. This narrowing restricts blood flow through the lungs, raising blood pressure in the lungs. Currently, vasodilators widen lung blood vessels and increase blood flow in patients with PAH. The researchers discovered that the fusion protein was more effective than vasodilators in treating PAH and preventing blood vessel remodeling by restoring a more normal balance of proliferation and cell death in the cells that make up blood vessel walls. For instance, when mice models were treated in the later stages of severe disease, the treatment increased the number of open lung vessels despite previous damage, in contrast to vasodilators, which did not. A wide range of fusion proteins have been studied in clinical trials, and several products are now available on the market. For instance, Amgen's Enbrel (etanercept) is used to treat moderate to severe plaque psoriasis, rheumatoid arthritis, and other diseases. A tumor necrosis factor receptor (TNFR) and an immunoglobulin (Ig) G1 Fc segment make up this TNF blocker. The TNFR provides specificity, while the Fc segment improves stability.The limitations associated with fusion proteins is expected to hamper the market growthFusion proteins are engineered proteins that contain domains from multiple proteins and immunoglobulin. Combining different proteins in one molecule can cause instability, posing upstream and downstream manufacturing challenges. These problems are being developed in academia and the pharmaceutical industry by equipment vendors and drug companies.Hence, the problems associated with developing fusion proteins for manufacturing purposes are expected to hamper the market growth.<h3>COVID-19 Impact Analysis</h3>The research using fused proteins to fight against COVID-19 is expected to have increased its market growth. For instance, SARS-CoV-2 uses angiotensin-converting enzyme 2 (ACE2) as a cell entry receptor to enter the host cell. According to studies, transiently produced human ACE2 fused with the Fc region of human IgG1 in Nicotiana benthamiana and tested the ACE2-Fc fusion protein's in vitro neutralisation efficacy. On day 6 post-infiltration, the recombinant ACE2-Fc fusion protein was expressed at 100 g/g leaf fresh weight in N. benthamiana. The recombinant fusion protein binds strongly to the SARS-CoV-2 receptor-binding domain (RBD). In addition, the plant-produced fusion protein demonstrated potent anti-SARS-CoV-2 activity in vitro. With an IC50 value of 0.84 g/ml, treatment with ACE2-Fc fusion protein after viral infection significantly inhibits SARS-CoV-2 infectivity in Vero cells.<h3>Segment Analysis</h3>Based on application biotechnology segment is expected to dominate the market growthBiotechnology tools can create molecules that contain genes or portions of genes for two proteins. The resulting fusion protein may have several properties that improve its ability to treat disease. Several fusion proteins, for instance, have been created by fusing the binding domain of a cell surface receptor with the tail (Fc) portion of an antibody. The receptor portion serves as a decoy binding site, attracting and trapping molecules that otherwise contribute to disease. The antibody component allows the fusion protein to remain in the body for much longer than a circulating receptor would.For instance, Etanercept is a soluble tumour necrosis factor-alpha (TNF) receptor fusion protein recombinant in humans. It is a large molecule with a molecular weight of 150 kDa that binds to TNF and reduces its role in autoimmune diseases such as ankylosing spondylitis, juvenile rheumatoid arthritis, psoriasis, psoriatic arthritis, rheumatoid arthritis, and, potentially, a variety of other disorders mediated by excess TNF. Etanercept is the most successful Fc-fusion protein, having outperformed the most successful therapeutic antibody, Bevacizumab. Etanercept was developed by researchers at Immunex, a biotechnology company later acquired by Amgen.<h3>Market Geographical Share</h3>North America region is expected to hold the largest market share in the global fusion proteins marketThe increasing research and developments are expected to drive the market in this region. For instance, a company based in the United States, Novus Biologicals, LLC, develops and markets novel lifescience products. Novus Biologicals is also organised to provide a mechanism for commercialising unique biological materials to the biological research community. The company contributes significantly to the advancement of biological research by making these products widely available to institutional and commercial researchers. They manufacture fused protein products such as mCherry Antibody,mCherry Antibody (1C51), Luciferase Antibody, and others in different applications.Hence, increasing companies in this region into the fused proteins market is expected to drive the market growth.<h3>Competitive Landscape</h3>The global fusion protein market is slightly competitive with mergers, collaborations and launches. Some key players are Abnova Corporation, Novus Biologicals, OriGene Technologies, Inc., Thermo Fisher Scientific Inc., PeproTech, Inc., ProSpec-Tany TechnoGene Ltd, F. Hoffmann-La Roche Ltd, Absolute Antibody., Amgen Inc, Sanofi S.A.Sanofi S.A.Overview: Sanofi S.A. is a multinational French healthcare corporation headquartered in Paris, France. By prescription sales, it is the world's fifth-largest pharmaceutical company. The company operates manufacturing sites in 32 countries and 21 research &amp; development sites.Product Portfolio: The company manufactures ELOCTATE [Antihemophilic Factor (Recombinant), Fc Fusion Protein] is an injectable medication used to help control and prevent bleeding in people who have Hemophilia A. (congenital Factor VIII deficiency).Why Purchase the Report?<ul><li>Visualize the composition of the global fusion proteins market segmentation by product and application, highlighting the key commercial assets and players.</li><li>Identify commercial opportunities in the global fusion proteins market by analyzing trends and co-development deals. </li><li>Excel data sheet with thousands of data points of global fusion proteins market-level 4/5 segmentation.</li><li>PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study. </li><li>Product mapping in excel for the key product of all major market players</li></ul>The global fusion proteins market report would provide access to an approx. 45+market data table, 40+ figures, and 180 pages.&nbsp;&nbsp;Target Audience<ul><li>Service Providers/ Buyers</li><li>Industry Investors/Investment Bankers</li><li>Education &amp; Research Institutes</li><li>Research Professionals</li><li>Emerging Companies</li><li>Manufacturers</li></ul><h3>Market Segmentation</h3>Global Fusion Proteins Market - By Product<ul><li>Immunoglobulin (Ig) fusion protein</li><li>Parathyroid hormone (PTH) fusion protein</li><li>Recombinant fusion protein</li><li>Other</li></ul>Global Fusion Proteins Market - By Application<ul><li>Biotechnology</li><li>Pharmaceutical</li><li>Others</li></ul>Global Fusion Proteins Market - By Region<ul><li>North America</li><li>Europe</li><li>South America</li><li>Asia Pacific</li><li>Middle East and Africa</li></ul>

<ol><li>Global Fusion Proteins Market Methodology and Scope<ol><li>Research Methodology</li><li>Research Objective and Scope of the Report</li></ol></li><li>Global Fusion Proteins Market – Market Definition and Overview</li><li>Global Fusion Proteins Market – Executive Summary<ol><li>Market Snippet By Product</li><li>Market Snippet By Application</li><li>Market Snippet By Region </li></ol></li><li>Global Fusion Proteins Market-Market Dynamics<ol><li>Market Impacting Factors<ol><li>Drivers<ol><li>The increasing applications of fusion proteins </li></ol></li><li>Restraints:<ol><li>The limitations associated with fusion proteins </li></ol></li><li>Opportunity</li><li>Impact Analysis</li></ol></li></ol></li><li>Global Fusion Proteins Market – Industry Analysis&nbsp;<ol><li>Porter's Five Forces Analysis </li><li>Epidemiology Analysis </li><li>Supply Chain Analysis</li><li>Pricing Analysis</li><li>Regulatory Analysis</li><li>Reimbursement Analysis</li><li>Unmet Needs</li></ol></li><li>Global Fusion Proteins Market – COVID-19 Analysis<ol><li>Analysis of Covid-19 on the Market<ol><li>Before COVID-19 Market Scenario</li><li>Present COVID-19 Market Scenario</li><li>After COVID-19 or Future Scenario</li></ol></li><li>Pricing Dynamics Amid Covid-19</li><li>Demand-Supply Spectrum</li><li>Government Initiatives Related to the Market During Pandemic</li><li>Manufacturers Strategic Initiatives</li><li>Conclusion </li></ol></li><li>Global Fusion Proteins Market – By Product<ol><li>Introduction<ol><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product </li><li>Market Attractiveness Index, By Product </li></ol></li><li>Immunoglobulin (Ig) fusion protein<ol><li>Introduction</li><li>Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029 </li></ol></li><li>Parathyroid hormone (PTH) fusion protein</li><li>Recombinant fusion protein</li><li>Other</li></ol></li><li>Global Fusion Proteins Market – By Application<ol><li>Introduction<ol><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application </li><li>Market Attractiveness Index, By Application </li></ol></li><li>Biotechnology*<ol><li>Introduction</li><li>Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029</li></ol></li><li>Pharmaceutical</li><li>Others</li></ol></li><li>Global Fusion Proteins Market – By Region<ol><li>Introduction<ol><li>Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region</li><li>Market Attractiveness Index, By Region</li></ol></li><li>North America<ol><li>Introduction</li><li>Key Region-Specific Dynamics</li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product</li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application</li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country<ol><li>U.S.</li><li>Canada</li><li>Mexico</li></ol></li></ol></li><li>Europe<ol><li>Introduction</li><li>Key Region-Specific Dynamics</li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product</li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application </li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country<ol><li>Germany</li><li>U.K.</li><li>France</li><li>Italy</li><li>Spain</li><li>Rest of Europe</li></ol></li></ol></li><li>South America<ol><li>Introduction</li><li>Key Region-Specific Dynamics</li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product</li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application</li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country<ol><li>Brazil</li><li>Argentina</li><li>Rest of South America</li></ol></li></ol></li><li>Asia Pacific<ol><li>Introduction</li><li>Key Region-Specific Dynamics</li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product</li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application </li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country<ol><li>China</li><li>India</li><li>Japan</li><li>Australia</li><li>Rest of Asia Pacific</li></ol></li></ol></li><li>Middle East and Africa<ol><li>Introduction</li><li>Key Region-Specific Dynamics</li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product</li><li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application </li></ol></li></ol></li><li>Global Fusion Proteins Market – Competitive Landscape<ol><li>Key Developments and Strategies </li><li>Company Share Analysis</li><li>Product Benchmarking</li></ol></li><li>Global Fusion Proteins Market Company Profiles<ol><li>Sanofi S.A.*<ol><li>Company Overview</li><li>Product Portfolio and Description</li><li>Key Highlights</li><li>Financial Overview</li></ol></li><li>Abnova Corporation</li><li>Novus Biologicals</li><li>OriGene Technologies, Inc.</li><li>Thermo Fisher Scientific Inc</li><li>PeproTech, Inc.</li><li> ProSpec-Tany TechnoGene Ltd</li><li>Hoffmann-La Roche Ltd</li><li>Absolute Antibody</li><li>Amgen Inc.(*LIST NOT EXHAUSTIVE)</li></ol></li><li>Global Fusion Proteins Market – DataM&nbsp;&nbsp; <ol><li>Appendix</li><li>About Us and Services</li><li>Contact Us</li></ol></li></ol>

List of TablesTable 01 Global Fusion Proteins Market Value, By Product, 2023, 2027 &amp; 2031($ Million)Table 02 Global Fusion Proteins Market Value, By Application, 2023, 2027 &amp; 2031($ Million)Table 03 Global Fusion Proteins Market Value, By Product, 2023, 2027 &amp; 2031($ Million)Table 04 Global Fusion Proteins Market Value, By Product, 2022-2031 ($ Million)Table 05 Global Fusion Proteins Market Value, By Application, 2023, 2027 &amp; 2031($ Million)Table 06 Global Fusion Proteins Market Value, By Application, 2022-2031 ($ Million)Table 07 Global Fusion Proteins Market Value, By Region, 2023, 2027 &amp; 2031($ Million)Table 08 Global Fusion Proteins Market Value, By Region, 2022-2031 ($ Million)Table 09 North America Fusion Proteins Market Value, By Product, 2022-2031 ($ Million)Table 10 North America Fusion Proteins Market Value, By Application, 2022-2031 ($ Million)Table 11 North America Fusion Proteins Market Value, By Country, 2022-2031 ($ Million)Table 12 South America Fusion Proteins Market Value, By Product, 2022-2031 ($ Million)Table 13 South America Fusion Proteins Market Value, By Application, 2022-2031 ($ Million)Table 14 South America Fusion Proteins Market Value, By Country, 2022-2031 ($ Million)Table 15 Europe Fusion Proteins Market Value, By Product, 2022-2031 ($ Million)Table 16 Europe Fusion Proteins Market Value, By Application, 2022-2031 ($ Million)Table 17 Europe Fusion Proteins Market Value, By Country, 2022-2031 ($ Million)Table 18 Asia-Pacific Fusion Proteins Market Value, By Product, 2022-2031 ($ Million)Table 19 Asia-Pacific Fusion Proteins Market Value, By Application, 2022-2031 ($ Million)Table 20 Asia-Pacific Fusion Proteins Market Value, By Country, 2022-2031 ($ Million)Table 21 Middle East &amp; Africa Fusion Proteins Market Value, By Product, 2022-2031 ($ Million)Table 22 Middle East &amp; Africa Fusion Proteins Market Value, By Application, 2022-2031 ($ Million)Table 23 Sanofi S.A.: OverviewTable 24 Sanofi S.A.: Product PortfolioTable 25 Sanofi S.A.: Key DevelopmentsTable 26 Abnova Corporation: OverviewTable 27 Abnova Corporation: Product PortfolioTable 28 Abnova Corporation: Key DevelopmentsTable 29 Novus Biologicals: OverviewTable 30 Novus Biologicals: Product PortfolioTable 31 Novus Biologicals: Key DevelopmentsTable 32 OriGene Technologies, Inc.: OverviewTable 33 OriGene Technologies, Inc.: Product PortfolioTable 34 OriGene Technologies, Inc.: Key DevelopmentsTable 35 Thermo Fisher Scientific Inc: OverviewTable 36 Thermo Fisher Scientific Inc: Product PortfolioTable 37 Thermo Fisher Scientific Inc: Key DevelopmentsTable 38 PeproTech, Inc.: OverviewTable 39 PeproTech, Inc.: Product PortfolioTable 40 PeproTech, Inc.: Key DevelopmentsTable 41 ProSpec-Tany TechnoGene Ltd: OverviewTable 42 ProSpec-Tany TechnoGene Ltd: Product PortfolioTable 43 ProSpec-Tany TechnoGene Ltd: Key DevelopmentsTable 44 Hoffmann-La Roche Ltd: OverviewTable 45 Hoffmann-La Roche Ltd: Product PortfolioTable 46 Hoffmann-La Roche Ltd: Key DevelopmentsTable 47 Absolute Antibody: OverviewTable 48 Absolute Antibody: Product PortfolioTable 49 Absolute Antibody: Key DevelopmentsTable 50 Amgen Inc.: OverviewTable 51 Amgen Inc.: Product PortfolioTable 52 Amgen Inc.: Key Developments&nbsp;List of FiguresFigure 01 Global Fusion Proteins Market Share, By Product, 2022 &amp; 2031(%)Figure 02 Global Fusion Proteins Market Share, By Application, 2022 &amp; 2031(%)Figure 03 Global Fusion Proteins Market Value, 2022-2031 ($ Million)Figure 04 Global Fusion Proteins Market Y-o-Y Growth, By Product, 2022-2031 (%)Figure 05 Immunoglobulin (Ig) fusion protein: Global Fusion Proteins Market Value, 2022-2031 ($ Million)Figure 06 Parathyroid hormone (PTH) fusion protein: Global Fusion Proteins Market Value, 2022-2031 ($ Million)Figure 07 Recombinant fusion protein: Global Fusion Proteins Market Value, 2022-2031 ($ Million)Figure 08 Other: Global Fusion Proteins Market Value, 2022-2031 ($ Million)Figure 09 Global Fusion Proteins Market Y-o-Y Growth, By Application, 2022-2031 (%)Figure 10 Biotechnology: Global Fusion Proteins Market Value, 2022-2031 ($ Million)Figure 11 Pharmaceutical: Global Fusion Proteins Market Value, 2022-2031 ($ Million)Figure 12 Others: Global Fusion Proteins Market Value, 2022-2031 ($ Million)Figure 13 Global Fusion Proteins Market Y-o-Y Growth, By Region, 2022-2031 (%)Figure 14 North America Fusion Proteins Market Value, 2022-2031 ($ Million)Figure 15 North America Fusion Proteins Market Share, By Product, 2022 &amp; 2031(%)Figure 16 North America Fusion Proteins Market Share, By Application, 2022 &amp; 2031(%)Figure 17 North America Fusion Proteins Market Share, By Country, 2022 &amp; 2031(%)Figure 18 South America Fusion Proteins Market Value, 2022-2031 ($ Million)Figure 19 South America Fusion Proteins Market Share, By Product, 2022 &amp; 2031(%)Figure 20 South America Fusion Proteins Market Share, By Application, 2022 &amp; 2031(%)Figure 21 South America Fusion Proteins Market Share, By Country, 2022 &amp; 2031(%)Figure 22 Europe Fusion Proteins Market Value, 2022-2031 ($ Million)Figure 23 Europe Fusion Proteins Market Share, By Product, 2022 &amp; 2031(%)Figure 24 Europe Fusion Proteins Market Share, By Application, 2022 &amp; 2031(%)Figure 25 Europe Fusion Proteins Market Share, By Country, 2022 &amp; 2031(%)Figure 26 Asia-Pacific Fusion Proteins Market Value, 2022-2031 ($ Million)Figure 27 Asia-Pacific Fusion Proteins Market Share, By Product, 2022 &amp; 2031(%)Figure 28 Asia-Pacific Fusion Proteins Market Share, By Application, 2022 &amp; 2031(%)Figure 29 Asia-Pacific Fusion Proteins Market Share, By Country, 2022 &amp; 2031(%)Figure 30 Middle East &amp; Africa Fusion Proteins Market Value, 2022-2031 ($ Million)Figure 31 Middle East &amp; Africa Fusion Proteins Market Share, By Product, 2022 &amp; 2031(%)Figure 32 Middle East &amp; Africa Fusion Proteins Market Share, By Application, 2022 &amp; 2031(%)Figure 33 Sanofi S.A.: FinancialsFigure 34 Abnova Corporation: FinancialsFigure 35 Novus Biologicals: FinancialsFigure 36 OriGene Technologies, Inc.: FinancialsFigure 37 Thermo Fisher Scientific Inc: FinancialsFigure 38 PeproTech, Inc.: FinancialsFigure 39 ProSpec-Tany TechnoGene Ltd: FinancialsFigure 40 Hoffmann-La Roche Ltd: FinancialsFigure 41 Absolute Antibody: FinancialsFigure 42 Amgen Inc.: Financials